Drawing for NAUTILUS

USPTO serial 73517089

NAUTILUS

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
SHALLANT, DAVID
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NAUTILUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

WILLIAM GREENAWAY

WILLIAM GREENAWAY NAUTILUS HEALTH AND BEAUTY AID PRODUCTSSTE 45MARWOOD RDPORT WASHINGTON, NY 11050

Goods and services

ClassDescriptionStatusFirst use
003TOILETRIES AND COSMETICS, FOR HAIR CARE, SKIN CARE, FOOT CARE AND GROOMING AIDS NAMELY AFTER-SHAVE LOTION, SHAMPOO, AND DEODORANTABANDONEDDec 21, 1984
008SHAVING RAZORSABANDONEDDec 21, 1984

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 9, 1986ABN1ABANDONMENT - EXPRESS MAILED—
Jan 27, 1986CNSLLETTER OF SUSPENSION MAILED—
Nov 25, 1985CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 1985CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 1985CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 20, 1985CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 1985DOCKASSIGNED TO EXAMINER—
Mar 15, 1985DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance